A share price of Apogee Therapeutics Inc [APGE] is currently trading at $63.1, up 0.24%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The APGE shares have gain 13.80% over the last week, with a monthly amount glided 20.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Apogee Therapeutics Inc [NASDAQ: APGE] stock has seen the most recent analyst activity on November 03, 2025, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $109. Previously, Mizuho started tracking the stock with Outperform rating on October 21, 2025, and set its price target to $105. On September 25, 2025, RBC Capital Mkts initiated with a Outperform rating and assigned a price target of $60 on the stock. BTIG Research reiterated its Buy rating and increased its price target to $115 on July 07, 2025. Citigroup initiated its recommendation with a Buy and recommended $95 as its price target on March 13, 2025. Canaccord Genuity started tracking with a Buy rating for this stock on November 25, 2024, and assigned it a price target of $89. In a note dated May 10, 2024, BofA Securities initiated an Buy rating and provided a target price of $80 on this stock.
Apogee Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $26.20 and $63.84. Currently, Wall Street analysts expect the stock to reach $84.5 within the next 12 months. Apogee Therapeutics Inc [NASDAQ: APGE] shares were valued at $63.1 at the most recent close of the market. An investor can expect a potential return of 33.91% based on the average APGE price forecast.
Analyzing the APGE fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.35 and Total Capital is -0.48. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 61.38 points at the first support level, and at 59.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 64.84, and for the 2nd resistance point, it is at 66.59.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Apogee Therapeutics Inc [NASDAQ:APGE] is 15.86. Further, the Quick Ratio stands at 15.86, while the Cash Ratio is 3.17.
Transactions by insiders
Recent insider trading involved JANE HENDERSON, Officer, that happened on Nov 11 ’25 when 1000.0 shares were purchased. Chief Medical Officer, Dambkowski Carl completed a deal on Nov 05 ’25 to sell 10785.0 shares. Meanwhile, Officer CARL DAMBKOWSKI bought 10785.0 shares on Nov 05 ’25.
